Trial
NCT05008913
Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
Parexel
Condition
Advanced Solid Tumors
Intervention
[14C]Adavosertib
Why stopped
Study terminated because the clinical development programme for Adavosertib has been discontinued
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-09-06